Refining genetic and molecular classifications to facilitate breakthrough treatments in intrahepatic cholangiocarcinoma: are we there yet?

Gut. 2023 Apr;72(4):608-610. doi: 10.1136/gutjnl-2022-327782. Epub 2022 Jun 30.
No abstract available

Keywords: CHOLANGIOCARCINOMA; IMMUNOLOGY.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Bile Duct Neoplasms* / genetics
  • Bile Ducts, Intrahepatic
  • Cholangiocarcinoma* / genetics
  • Humans